• Michael Cais


The role of metal ions in biological processes has received increasing attention in recent years both among inorganic chemists and biochemists. The emergence of “bioinorganic chemistry” as a discipline in its own rights is attested to by the appearence of new scientific journals and many symposia devoted entirely or largely to the area of bioinorganic chemistry research in general and to metallobiochemistry in particular.


Estrogen Receptor Platinum Compound Allylic Alcohol Label Agent Estrogen Conjugate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham, G.E., 1977, “Handbook of Radioimmunoassay,” Decker, New York.Google Scholar
  2. Barton, H.R. and Patin, H., 1977, Palladium Chloride-π-allyl complexes from calciferol and related compounds, J. Chem. Soc. Chem. Commun. 15: 799–800.CrossRefGoogle Scholar
  3. Beck, W.M., Calabrese, J.C. and Kottmair, N.D., 1979, Palladium(II) and platinum(II) complexes with nucleobases and nucleosides. Crystal structure of trans-bis(adeninato)bis(tri-n-butylphosphine)palladium (II), Inorg. Chem. 18: 176–182.CrossRefGoogle Scholar
  4. Cais, M., Dani, S., Eden, Y., Gandolfi, O., Horn, M., Isaacs, E.E., Josephi, Y., Saar, E., Slovin, E., and Snarsky, L., 1977, Metalloimmunoassay, Nature (London) 270: 534–535.CrossRefGoogle Scholar
  5. Cais, M., Slovin, E. and Snarsky, L., 1978, Metalloimunoassay. II., Ironmetallohaptens from estrogen steroids, J. Organometal. Chem. 160: 223–230.CrossRefGoogle Scholar
  6. Cais, M., 1979, Tests immunologiques à l’aide des complexes organométalliques. Un nouveau concept, 1979, L’actualité chimique 7: 14–26.Google Scholar
  7. Cais, M. and Josephi, Y., 1977, unpublished results; also Josephi, Y., 1979, D.Sc. Thesis, Technion-Israel Inst. of Technology, Haifa, Israel.Google Scholar
  8. Cais, M. and Adler, R., 1979, unpublished results; also Adler, R., 1980, M.Sc. Thesis, Technion-Israel Inst. of Technology, Haifa, Israel.Google Scholar
  9. Cais, M., 1980, Specific binding assay method and reagent means, U.S. Patent No. 4205952.Google Scholar
  10. Cais, M. and Shimoni, M., 1980, unpublished results; also Shimoni, M., 1981, D.Sc. Thesis, Technion-Israel Inst. of Technology, Haifa, Israel.Google Scholar
  11. Cais, M. and Tirosh, N., 1981, Metalloimmunoassay. IV. Manganese-labelied metallohaptens via cymantrene derivatives, Bull. Soc. Chim. Belg. 90: 27–35.CrossRefGoogle Scholar
  12. Cais, M. and Shimoni, M., 1981a, A feasible solvent separation system for immunoassays, Ann. Clin. Biochem. 18: 317–323.PubMedGoogle Scholar
  13. Cais, M. and Shimoni, M., 1981b, A novel system for mass transport through selective barriers in non-centrifugation immunoassays, Ann. Clin. Biochem. 18: 324–329.PubMedGoogle Scholar
  14. Cais, M., 1983a, Metalloimmunoassay: principles and practice, Methods in Enzymology 92: 445–458.PubMedCrossRefGoogle Scholar
  15. Cais, M., 1983b, Non-centrifugation imraunoassays: novel systems, Methods in Enzymology 92: 336–344.PubMedCrossRefGoogle Scholar
  16. Cais, M., Cwikel, D., Agmon, I., and Kapon, M., 1986, Studies towards the synthesis of potentially selective antitumor cis-platinum(II)-coraplexes, Abstracts, XXIVth Int. Conf. on Coordination Chem., Athens, Greece.Google Scholar
  17. Cass, A.E.G., Davis, D., Francis, G.D., Hill, H.A.O., Aston, W.J., Higgins, I.J., Plotkin, E.V., Scott, L.D.L., and Turner, A.P.F., 1984, Ferrocene-mediated enzyme electrode for amperometric determination of glucose, Anal. Chem. 56: 667–671.PubMedCrossRefGoogle Scholar
  18. Cass, A.E.G., Davis, G., Green, M.J., and Hill, H.A.O., 1985, Ferricinium as one electron acceptor for oxido-reductases, J. Electroanal. Chem. 190: 117–127.CrossRefGoogle Scholar
  19. Chu, G.Y.H., Duncan, R.E. and Tobias, R.S., 1977, Heavy metal-nucleoside interactions. 10. Binding of cis-diammine platinum(II) to cytidine and uridine in aqueous solutions: necessary conditions for formation of platinum-uridine “blues,” Inorg. Chem. 16: 2625–2636.Google Scholar
  20. Collins, W.P., Barnard, G.J.R. and Hennam, J.F., 1975, Factors affecting the choice of separation technique, in “Stereoid Immunoassays” (Cameron, E.H.D., Hillier, S.G. and Griffiths, K., eds.) pp. 223–228, Alpha Omega, Cardiff.Google Scholar
  21. Daughaday, W.H. and Jacobs, L.S., 1971, in “Principles of Competitive Protein Binding Assays,” (Odell, W.D. and Daughaday, W.H., eds.) pp. 303–316, J.B. Lippincott Co., Philadelphia.Google Scholar
  22. Dehand, J. and Jordanov, J., 1977, Binding of cis-dichlorobis(1-methyl-imidazole-2-thiol)-palladium(II) and-platinum(II) to nucleosides: synthesis and hydrogen-1 and carbon-13 nuclear magnetic resonance studies, J. Chem. Soc. Dalton Trans. 1588-1593.Google Scholar
  23. DiGleria, K., Hill, H.A.O., McNeil, J., and Green, M.J., 1986, Homogeneous ferrocene-mediated amperometric immunoassay, Anal. Chem. 58: 1203–1205.CrossRefGoogle Scholar
  24. Doyle, M.J., Halsall, H.B. and Heineman, W.R., 1982, Heterogeneous immunoassay for serum proteins by differential pulse anodic stripping voltametry, Anal. Chem. 54: 2318–2322.PubMedCrossRefGoogle Scholar
  25. Gandolfi, O., Dolcetti, G., Ghedini, M. and Cais, M., 1980, Metal catecholato complexes: a source for metallo-labelling antigens, Inorg. Chem. 19: 1785–1791.CrossRefGoogle Scholar
  26. Gandolfi, O., Cais, M., Dolcetti, G., Ghedini, M., and Modiano, A., 1981, Metalloimmunoassay. V. Steroid-platinum(II)-o-catecholato complexes: a novel set of metallohaptens, Inorg. Chim. Acta 56: 127–133.CrossRefGoogle Scholar
  27. Gorski, J., Toft, D., Shyaraala, G., Smith, D., and Notides, A., 1968, Hormone receptors: studies on the interaction of estrogen with the uterus, Rec. Progr. Hormone Res. 24: 54–80.Google Scholar
  28. Hadjiliadis, N., Kourounakis, P. and Theophanides, T., 1973, Interactions of platinum(II) with adenosine and its acetyl derivatives, Inorg. Chim. Acta 7: 226–230.CrossRefGoogle Scholar
  29. Hadjiliadis, N. and Theophanides, T., 1976, Platinum purine nucleosides. I. Interaction of K2PtX4 (X=Cl, Br) with adenosine, triacetyladenosine, adenosine-1-oxide ana 9-methyladenine, Inorg. Chim. Acta 16: 67–75.CrossRefGoogle Scholar
  30. Hadjiliadis, N. and Theophanides, T., 1976, Platinum purine nucleosides. II. Interaction of K2PtX4 (X=Cl, Br) with inosine and guanosine, Inorg. Chim. Acta 16: 77–88.CrossRefGoogle Scholar
  31. Hadjiliadis, N. and Pneumatikakis, G., 1978, Complexes of palladium (II) with nucleosides. Preparation and properties of complexes of the type potassium trichloro(nucleoside)palladate(II), J. Chem. Soc. Dalton Trans. 1691-1695.Google Scholar
  32. Harvie, I.J. and McQuillin, F.J., 1978, Steric mechanism of formation of the PdCl π-allyl derivative from [6β-2H]cholest-4-ene, J. Chem. Soc. Chem. Commun. 747-748.Google Scholar
  33. Heineman, W.R., Anderson, C.W. and Halsall, H.B., 1979, Immunoassay by differential pulse polarography, Science 204: 865–866.PubMedCrossRefGoogle Scholar
  34. Henderson, K. and McQuillin, F.J., 1978, Mechanism of formation of 4-6n-3-oxo stereoid-PdC1 complexes, J. Chem. Soc. Chem. Commun. 15-16.Google Scholar
  35. Jensen, E.V., De Sombre, E.R. and Jungblut, P.W., 1967, in “Endogenous Factors Influencing Host-Tumor Balance” (Wissler, R.W., Dao, T.L. and Wood, S., Jr., eds.) University of Chicago Press, Chicago.Google Scholar
  36. Jensen, E.V., Numata, M., Smith, S., Suzuki, T., and De Sombre, R.E., 1969, Estrogen receptor interaction in target tissues, in Action Horm. Syrap., 20–39 (Foa P.P. ed.), Thomas, Springfield, I11.Google Scholar
  37. Jensen, E.V. and De Sombre, E.R., 1973, Estrogen-receptor interaction, Science 182: 126–134.PubMedCrossRefGoogle Scholar
  38. Jones, D.N. and Knox, S.D., 1975, Regioselective and stereoselective oxidation of steroidal palladium π-allyl complexes to allylic alcohols, J. Chem. Soc. Chem. Commun. 166-167.Google Scholar
  39. Katzenellenbogen, J.A., Heiman, D.F., Carlson, K.E., Payne, D.W., and Lloyd, J.E., 1974, in “Cytotoxic Estrogens in Hormone Receptive Tumors” (Raus, J., Martens, H. and Leclercq, G., eds.), Academic Press, New York.Google Scholar
  40. King, R.T.B., 1979, “Steroid Receptor Assays in Human Breast Tumors,” Alpha Omega, Cardiff.Google Scholar
  41. Lange, R.C., Spencer, R.P. and Harder, H.C., 1972, Synthesis and distribution of a radio labeled antitumor agent: cis-diamminedichloroplatinum(II), J. Nucl. Med. 13: 328–330.PubMedGoogle Scholar
  42. Lange, R.C., Spencer, R.P. and Harder, H.C., 1973, Antitumor agents cisdiamminedichloroplatinum. Distribution studies and dose calculations for platinum-193m and platinum-195m, J. Nucl. Med. 14: 191–195.PubMedGoogle Scholar
  43. Leh, F.K.V. and Wolf, W., 1976, Platinum complexes: a new class of antineoplastic agents, J. Pharm. Sci. 65: 315–328.PubMedCrossRefGoogle Scholar
  44. Liao, S., 1975, Cellular receptors and mechanisms of action of steroid hormones, Int. Rev. Cytol. 40: 87–172.CrossRefGoogle Scholar
  45. Marzilli, L.G. and Kistenmacher, T.G., 1977, Stereoselectivity in the binding of transition metal-chelate complexes to nucleic acid consistuents: bonding and nonbonding effects, Acc. Chem. Res. 10: 146–152.CrossRefGoogle Scholar
  46. McGuire, W.L., Carbone, P.P. and Volmer E.P., 1975, “Estrogen Receptors in Human Breast Cancer,” Raven Press, New York.Google Scholar
  47. Monoclonal Antibodies and Ultrasensitive Immunoassay in Human Diagnosis and Monitoring of Therapy, 1981, RIA 81 Symposium, Gardone Riviera, Italy.Google Scholar
  48. Muldoon, T.G. and Warren, J.C., 1969, Characterization of steroid-binding sites by affinity labelling. II. Biological activity of 4-mercuri-17β-estradiol, J. Biol. Chem. 244: 5430–5435.PubMedGoogle Scholar
  49. Muldoon, T.G., 1971, Characterization of steroid-binding sites by affinity labeling. Further studies of the interaction between 4-mercuri-17β-estradiol and specific estrogen-binding proteins in the rat uterus, Biochemistry 10: 3780–3784.PubMedCrossRefGoogle Scholar
  50. Muldoon, T.G., 1980, Molecular and functional anomalies in the mechanism of the estrogenic action of 4-merciou-17β-estradiol, J-Biol. Chem. 255: 1358–1366.PubMedGoogle Scholar
  51. Oddel, W.D., Silver, C. and Grover, P.K., 1975, Competitive protein binding assays: methods of separation of bound from free, “Steroid Imraunoassays” (Cameron, E.H.D., Hillier, S.G. and Grover, P.K., eds.) pp. 207–222, Alpha Omega, Cardiff.Google Scholar
  52. Pneumatikakis, G., Hadjiliadis, N. and Theophanides, T., 1977, Palladium reactions with guanosine. Definitive evidence of O6N6 chelation, Inorg. Chim. Acta 22: L1–L2.CrossRefGoogle Scholar
  53. Pneumatikakis, G., Hadjiliadis, N. and Theopanides, T., 1978, Complexes of inosine, cytidine and guanosine with palladium(II), Inorg. Chem. 17: 915–922.CrossRefGoogle Scholar
  54. Ratcliffe, J.G., 1974, Separation techniques in saturation analysis, Br. Med. Bull. 30: 32–37.PubMedGoogle Scholar
  55. Rosenberg, B., VanCamp, L., Trosko, J.E., and Mansour, V.H., 1969, Platinum compounds: a new class of potent antitumor agents, Nature (London) 222: 385–386.CrossRefGoogle Scholar
  56. Shani, J., Lieberman, L.M., Samuni, T., Schlesinger, M., and Cais, M., 1982, Tissue distribution of 2− and 4−[203 Hg]estradiol in mammary-tumor-bearing rats, Int. J. Nucl. Med. Biol. 9: 251–255.PubMedCrossRefGoogle Scholar
  57. Thorell, J.I. and Larson, S.M., 1978, “Radioimmunoassay Techniques,” C.V. Mosby, Saint Louis.Google Scholar
  58. Trost, B.M. and Verhoeven, T.R., 1976, New synthetic reactions. Catalytic vs. stoichiometric allylic alkylation. Stereocontrolled approach to steroid side chain, J. Am. Chem. Soc. 98: 630–632.PubMedCrossRefGoogle Scholar
  59. Trost, B.M. and Verhoeven, T.R., 1978, Stereocontrolled approach to steroid side chain via organometallic chemistry. Partial synthesis of 5α-cholestanone, J. Am. Chem. Soc. 100: 3435–3443.CrossRefGoogle Scholar
  60. Weber, S.G. and Purdy, W.C., 1979, Homogeneous voltametric immunoassay: a preliminary study, Anal. Letters 12: 1–9.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Michael Cais
    • 1
  1. 1.Department of ChemistryTechnion Israel Institute of TechnologyHaifaIsrael

Personalised recommendations